Immunosuppression Reactivates and Disseminates Latent murine Cytomegalovirus

References

1. Abdallah P. S., Mark J. B. D., Merigan J. C. 1976; Diagnosis of cytomegalovirus pneumonia in compromised hosts. The American Journal of Medicine 61:326–332
   [Google Scholar]
2. Brodsky L., Rowe W. P. 1958; Chronic subclinical infection with mouse salivary gland virus. Proceedings of the Society for Experimental Biology and Medicine 99:654–655
   [Google Scholar]
3. Gardner M. R., Officer J. E., Parker J., Estes J. D., Rongey R. W. 1974; Induction of disseminated virulent cytomegalovirus infection by immunosuppression of naturally chronically infected wild mice. Infection and Immunity 10:966–969
   [Google Scholar]
4. Henson D., Smith R. D., Gehrke J. 1966; Non-fatal mouse cytomegalovirus hepatitis. American Journal of Pathology 49:871–880
   [Google Scholar]
5. Hudson J. B., Misra V., Mosmann T. R. 1976; Cytomegalovirus infectivity: analysis of the phenomenon of centrifugal enhancement of infectivity. Virology 72:235–243
   [Google Scholar]
6. Lang D. J. 1972; Cytomegalovirus infections in organ transplantation and post-transfusion. Archiv für die Gesamte Virusforschung 37:365–377
   [Google Scholar]
7. Lang D. J., Cheung K. S., Schwartz J. N., Daniels C. A., Harwood S. E. 1976; Cytomegalovirus replication and the host immune response. Yale Journal of Biology and Medicine 49:45–48
   [Google Scholar]
8. Mannini A., Medearis D. N. 1961; Mouse salivary gland virus infections. American Journal of Hygiene 73:329–343
   [Google Scholar]
9. Medearis D. N. 1964; Mouse cytomegalovirus infection. II. Observations during prolonged infection. American Journal of Hygiene 80:103–112
   [Google Scholar]
10. Meyers J. D., Spencer H. C., Watts J. C., Gregg M. B., Stewart J. A., Troupin R. H., Thomas E. D. 1975; Cytomegalovirus pneumonia after human marrow transplantation. Annals of Internal Medicine 82:181–188
    [Google Scholar]
11. Olding L. B., Jensen F. C., Oldstone M. B. A. 1975; Pathogenesis of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. Journal of Experimental Medicine 141:561–572
    [Google Scholar]
12. Olding L. B., Kingsbury D. T., Oldstone M. B. A. 1976; Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes, and autoimmunity during latent murine infection. Journal of General Virology 33:267–280
    [Google Scholar]
13. Osborn J. E., Walker D. L. 1968; Enhancement of infectivity of murine cytomegalovirus in vitro by centrifugal inoculation. Journal of Virology 2:853–858
    [Google Scholar]
14. Osborn J. E., Walker D. L. 1970; Virulence and attentuation of murine cytomegalovirus. Infection and Immunity 3:228–236
    [Google Scholar]
15. Prince A. M., Szmuness W., Millian S. J., David D. S. 1971; A serologic study of cytomegalovirus infection associated with blood transfusions. New England Journal of Medicine 284:1125–1131
    [Google Scholar]
16. Rifkind D., Goodman N., Hill R. B. 1967; The clinical significance of cytomegalovirus infection in renal transplant recipients. Annals of Internal Medicine 66:1116–1128
    [Google Scholar]
17. Selgrade M. K., Osborn J. E. 1974; Role of macrophages in resistance to murine cytomegalovirus. Infection and Immunity 10:1383–1390
    [Google Scholar]
18. Stevens J. G. 1977; Latent characteristics of selected herpesviruses. Advances in Cancer Research (in the press)
    [Google Scholar]
19. Weller T. H. 1971; The cytomegaloviruses: ubiquitous agents with protein clinical manifestations. New England Journal of Medicine 285:203 267–274
    [Google Scholar]
20. Wu B. C., Dowling J. N., Armstrong J. A., Ho M. 1975; Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science 190:56–58
    [Google Scholar]